|
Repurposed Antifibrinolytic Agents as a Substitute for Platelet Transfusions to Prevent Bleeding in Severe Thrombocytopenia Patients
Application
Prophylactic administration of an antifibrinolytic agent, epsilon aminocaproic acid (EACA), to prevent bleeding in patients with thrombocytopenia from hematological malignancies.
Key Benefits
Orally bioavailable, repurposed drug.
Commonly used and FDA approved to manage hemorrhage in patients with congenital bleeding.
Cheaper and...
Published: 7/28/2023
Contributor(s): Hanna Khoury, Ana Antun
|